Search research articles
Contact Us
Filters
Showing results (111-120 of 118) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 118 results.
European Urology Oncology
|
March 1, 2024
Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients
Natalia Jiménez, Marta Garcia de Herreros, Òscar Reig, et al.
NPJ Vaccines
|
September 29, 2023
Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2
Lorna Leal, Judit Pich, Laura Ferrer, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
November 9, 2023
Guidelines for establishing a cytometry laboratory
Anna C Belkina, Caroline E Roe, Vera A Tang, et al.
Breast Cancer Research and Treatment
|
February 24, 2025
Considerations for hereditary breast and ovarian cancer syndrome molecular diagnosis: experience from the clinical practice
Miriam Potrony, Blai Morales-Romero, Lorena Moreno, et al.
Iscience
|
February 7, 2023
Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2
Antonio Barreiro, Antoni Prenafeta, Gregori Bech-Sabat, et al.
Journal of Youth and Adolescence
|
April 9, 2025
Global Profiles of Positive Youth Development: A Person-Oriented Analysis among Emerging Adults Living in 21 Countries
Jet Uy Buenconsejo, Laura Ferrer-Wreder, Radosveta Dimitrova, et al.
Vaccine
|
January 14, 2025
Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial
Júlia Corominas, Carme Garriga, Antoni Prenafeta, et al.
The Lancet Regional Health. Europe
|
May 3, 2023
Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial
Júlia Corominas, Carme Garriga, Antoni Prenafeta, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 118) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 118 results.
European Urology Oncology
|
March 1, 2024
Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients
Natalia Jiménez, Marta Garcia de Herreros, Òscar Reig, et al.
NPJ Vaccines
|
September 29, 2023
Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2
Lorna Leal, Judit Pich, Laura Ferrer, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
November 9, 2023
Guidelines for establishing a cytometry laboratory
Anna C Belkina, Caroline E Roe, Vera A Tang, et al.
Breast Cancer Research and Treatment
|
February 24, 2025
Considerations for hereditary breast and ovarian cancer syndrome molecular diagnosis: experience from the clinical practice
Miriam Potrony, Blai Morales-Romero, Lorena Moreno, et al.
Iscience
|
February 7, 2023
Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2
Antonio Barreiro, Antoni Prenafeta, Gregori Bech-Sabat, et al.
Journal of Youth and Adolescence
|
April 9, 2025
Global Profiles of Positive Youth Development: A Person-Oriented Analysis among Emerging Adults Living in 21 Countries
Jet Uy Buenconsejo, Laura Ferrer-Wreder, Radosveta Dimitrova, et al.
Vaccine
|
January 14, 2025
Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial
Júlia Corominas, Carme Garriga, Antoni Prenafeta, et al.
The Lancet Regional Health. Europe
|
May 3, 2023
Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial
Júlia Corominas, Carme Garriga, Antoni Prenafeta, et al.
Page
of 12